During the past decade, hôpital du Cluzeau conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "hôpital du Cluzeau" #1 sponsor was "Groupe Francais De Pneumo-Cancerologie" with 5 trials, followed by "Intergroupe Francophone de Cancerologie Thoracique" with 5 trials sponsored, "Ipsen" with 2 trials sponsored, "Centre Hospitalier Intercommunal Creteil" with 1 trials sponsored and "ETOP IBCSG Partners Foundation" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "hôpital du Cluzeau" #1 collaborator was "Groupe Francais De Pneumo-Cancerologie" with 3 trials as a collaborator, "Amgen" with 2 trials as a collaborator, "Baxter Healthcare Corporation" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "University Hospital, Caen" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "hôpital du Cluzeau" are "Carcinoma, Non-Small-Cell Lung" (3 trials), "Acromegaly" (2 trials), "Non-Small Cell Lung Cancer" (2 trials), "Non-small Cell Lung Cancer" (2 trials) and "ALK Gene Mutation" (1 trials). Many other conditions were trialed in "hôpital du Cluzeau" in a lesser frequency.

Most popular intervention types in "hôpital du Cluzeau" are "Drug" (9 trials), "Other" (2 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cisplatin" (4 trials), "Carboplatin" (2 trials), "Gemcitabine" (2 trials), "Pemetrexed" (2 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "hôpital du Cluzeau" are 18 trials for "All" genders.

Currently, there are NaN active trials in "hôpital du Cluzeau". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in hôpital du Cluzeau, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in hôpital du Cluzeau, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".